Innovation Lab

Its activities are structured around two main areas:

1. Investigation and evaluation of tissue regeneration mechanisms across musculoskeletal, cardiac, mucosal, and cutaneous systems.

This includes the design of 3D cell and tissue models that closely reproduce clinical microenvironments and enable the evaluation of biomaterials, medical devices, drugs, and advanced therapies. Within this area, the Lab contributes to several European initiatives — including INJECTHEAL, REBONE, FORCE REPAIR, and BIOACTION — offering expertise in cytocompatibility and antibacterial testing, wound-healing assays, and biointerface characterization.

2. Development of advanced biomaterials and smart systems for tissue repair and functional recovery. 

Research focuses on amorphous metals and metallic-glass materials, explored as conductive, bioactive, and mechanically adaptive components for dental, orthopedic, and regenerative applications. These materials serve as active elements in next-generation scaffolds, hydrogels, and bioelectronic interfaces, aligned with current efforts in cardiac and musculoskeletal regeneration, and supported by fundings such as the Fondo Italiano per la Scienza (FIS, ERC in Italy).

The Innovation Lab participates in major national and international programmes — including Horizon Europe, MSCA Doctoral Networks, and PRIN — and collaborates with industry through ISO-compliant analytical and certification services for CE marking and translational validation.

For more details, visit:www.theinnovationlab.it

Keywords

Regenerative medicine; Bioengineering; Tissue engineering; Biomaterials; Amorphous metals; Metallic glasses; 3D tissue models; Wound healing; Cardiac regeneration; Bioelectronic interfaces; New Approach Methodologies (NAMs); Industrial R&D; ISO & CE compliance.

Publications

Lia Rimondini: UPO IRIS; PUBMED

Andrea Cochis: UPO IRIS; PUBMED

Elham Sharifikolouei: UPO IRIS; PUBMED

Group members